Moderna Covid-19 Vaccine Hailed as Benefit of US-Israel Cooperation
America’s envoy to the Jewish state on Monday hailed US-Israel cooperation after Moderna announced that its experimental Covid-19 vaccine was 94.5% effective in preventing the disease.
By Algemeiner Staff
Noting that Moderna’s chief medical officer, Tal Zaks, was an Israeli who studied at Ben-Gurion University of the Negev, Ambassador David Friedman tweeted, “Another great example of Israelis and Americans working together to make the world a better place!”
Zaks told BBC News, “The overall effectiveness has been remarkable… it’s a great day.”
In early June, as reported by The Algemeiner, Zaks credited “the first-rate education” he got at Ben-Gurion University, but noted that the story of how Israel put him on his present course “actually starts from the times I was a medic in the IDF.”
At the time, Zaks predicted Massachusetts-based Moderna would be able to produce “a billion doses” of a Covid-19 vaccine in 2021.
Later in June, Israel signed a deal with Moderna for the future purchase of its vaccine.
No comments:
Post a Comment